609 related articles for article (PubMed ID: 12592224)
41. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
[TBL] [Abstract][Full Text] [Related]
42. Barrett's esophagus and Barrett's-related dysplasia.
Goldblum JR
Mod Pathol; 2003 Apr; 16(4):316-24. PubMed ID: 12692197
[TBL] [Abstract][Full Text] [Related]
43. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J
Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
[TBL] [Abstract][Full Text] [Related]
44. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
Lassen A; Hallas J; de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
[TBL] [Abstract][Full Text] [Related]
45. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
Dent J
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
[TBL] [Abstract][Full Text] [Related]
46. [Barrett's esophagus: characteristics and evaluation of risk of malignancy].
Spinelli P; Falsitta M
Ann Ital Chir; 1990; 61(5):531-7; discussion 537-8. PubMed ID: 2100972
[TBL] [Abstract][Full Text] [Related]
47. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
48. Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
[TBL] [Abstract][Full Text] [Related]
49. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
[TBL] [Abstract][Full Text] [Related]
50. Barrett's oesophagus: results from a 13-year surveillance programme.
Bani-Hani K; Sue-Ling H; Johnston D; Axon AT; Martin IG
Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):649-54. PubMed ID: 10912484
[TBL] [Abstract][Full Text] [Related]
51. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
52. Are screening and surveillance for Barrett's oesophagus really worthwhile?
Sharma P; Sidorenko EI
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
[TBL] [Abstract][Full Text] [Related]
53. Screening for Barrett's esophagus.
Spechler SJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
55. [Barrett esophagus--an increasing problem].
Berstad A; Hatlebakk JG; Giercksky KE
Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4100-3. PubMed ID: 9844516
[TBL] [Abstract][Full Text] [Related]
56. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.
Toruner M; Soykan I; Ensari A; Kuzu I; Yurdaydin C; Ozden A
J Gastroenterol Hepatol; 2004 May; 19(5):535-40. PubMed ID: 15086597
[TBL] [Abstract][Full Text] [Related]
57. Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia.
Benipal P; Garewal HS; Sampliner RE; Martinez P; Hayden CW; Fass R
Am J Gastroenterol; 2001 Nov; 96(11):3084-8. PubMed ID: 11721753
[TBL] [Abstract][Full Text] [Related]
58. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy.
Johnston MH; Hammond AS; Laskin W; Jones DM
Am J Gastroenterol; 1996 Aug; 91(8):1507-11. PubMed ID: 8759651
[TBL] [Abstract][Full Text] [Related]
59. [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance].
Burdiles P; Csendes A; Smok G; Braghetto I; Korn O
Rev Med Chil; 2003 Jun; 131(6):587-96. PubMed ID: 12942585
[TBL] [Abstract][Full Text] [Related]
60. [Barrett's esophagus].
Duque JM; Betés MT; de la Riva S; Súbtil JC; Muñoz-Navas M
Rev Med Univ Navarra; 1998; 42(3):145-55. PubMed ID: 10420937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]